Seung Cha^*, Morgan Charbonneau^*, Alfonso Brito^*, Ania Habibi^*, Christina Pham^* and Cokey Nguyen^*

Atara Biotherapeutics, Thousand Oaks, CA

Lanny Gov, PhD^*, Jiaji Yu, PhD^*, Maha Qubain^*, Saige L Pompura, PhD^*, Sean D Allen, PhD^*, Michael A Christopher, PhD^* and Jeff Wiezorek, MD

Appia Bio, Culver City, CA

Jian Fu^1*, Lixiang Jiang^1,2*, Zhibin Zhu^1*, Yubo Yan^1*, Guojin Wu, PhD^3*, Mingjun Wei^1*, Jinying Ning, PhD^3* and Jiayin Yang, PhD^1,2*

¹Cell Inspire Biotechnology, Shenzhen, China
²Cell Inspire Therapeutics, Shenzhen, China
³KYinno Biotechnology (Beijing) Co., Ltd., Beijing, China

Emily J Pomeroy, PhD^*, Andrew V Anzalone, MD, PhD^*, Christopher J Podracky, PhD^*, Noah B Bloch, PhD^*, Reyna Chang^*, Arika A Dwivedi^*, Kanut Laoharawee, PhD^*, Alan J Wilhelm^*, David P Waterman, PhD^*, Justin G Tedeschi^*, Upasana Sunil Arvindam, PhD^*, Elizabeth R Macari, PhD, Jennifer L Gori, PhD and Jeremy S Duffield, MD, PhD^*

Prime Medicine, Inc., Cambridge, MA

Francesco Di Meo^1*, Samuel John, MD^2*, Chengcheng Zhang, PhD^3*, Ciara Louise L. Freeman, MD, PhD, MSc⁴ and Fabiana Perna, MD, PhD⁵

¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
²Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA, Dallas, TX
³Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA, Dallas, TX
⁴Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Sophia Stock^1,2,3*, Thaddaeus Strzalkowski^1*, Adrian Gottschlich, MD^1,2*, Lisa Rohrbacher, MSc^2,4*, Luisa Fertig^1*, Vivien D. Menkhoff^1*, Marlena Surowka^5*, Peter Bruenker, PhD^5*, Diana Darowski, PhD^5*, Stefan Endres, MD, Prof^1,3,6*, Michael von Bergwelt-Baildon, MD, PhD^2,3*, Marion Subklewe, MD^3,7,8, Christian Klein, PhD⁵ and Sebastian Kobold, MD, Prof^1,3,6*

¹Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany
²Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
³German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
⁴Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany
⁵Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland
⁶Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany
⁷LMU University Hospital, Munich, Germany
⁸Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany

Heather Lin¹, Dejah Blake¹, Abhijay Mudigonda, BS^2*, Alysa N Evans, BS^2*, Ruby Freeman^1*, Tanisha Sinha, BS^2*, Fan Fei, BS^2*, Elyse Christensen, BS^2*, Tenzin Passang Fnu, BS^2*, Sruthi Ravindranathan, PhD^2*, Tongrui Liu, PhD^3*, Lily Yang, MD PhD^3*, Edmund K. Waller, MD² and Sarwish Rafiq, PhD¹

¹Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA
²Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
³Department of Surgery, Emory University School of Medicine, Atlanta, GA

Vincent Allain^1,2,3*, Allison Rothrock^1,2*, William Nyberg, PhD^1,2*, Joseph Muldoon, PhD^1,4*, Angela To^1,2*, Jing-Yi Chung^1,2*, Christopher Chang^1,2*, Alexis Talbot, MD^1,3,4* and Justin Eyquem, PhD^1,4,5,6,7,8*

¹Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA
²Department of Medicine, University of California, San Francisco, San Francisco, CA
³Université de Paris, INSERM UMR976, Hôpital Saint-Louis, Paris, France
⁴Department of Medicine, University of California, San Francisco, CA
⁵Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA
⁶Department of Microbiology and Immunology, University of California, San Francisco, CA
⁷UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
⁸Institute for Human Genetics, University of California, San Francisco, San Francisco, CA

Sophia Chen^1*, Alexander P. Boardman^2*, Scott E. James^1,3,4,5 and Marcel R.M. van den Brink^1,3,4

¹Department of Immunology, Sloan Kettering Institute, New York, NY
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Weill Cornell Medical College, New York, NY
⁵Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY

Luciana Melo Garcia, MD, MSc¹, Achintyan Gangadharan^2,3*, Pinaki Banerjee, PhD^4*, Paul Lin, MD, PhD⁴, May Daher, MD⁵, Hind Rafei, MD⁴, Bijender Kumar^5* and Katy Rezvani, MD⁶

¹CHU de Québec - Université Laval, Quebec, QC, Canada
²Department of Imunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Cancer Biology PhD Program, University of South Florida, Tampa, FL
⁴Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

Zhimai Gao^1*, Fan Wu^1*, Cong Li, PhD^2*, Huiping Wang^1*, Xue Liang, PhD^3* and Zhimin Zhai, MD⁴

¹Hematologic Department/Hematologic Diseases Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
²Hematologic Department/Hematologic Diseases Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, China
³Hematologic Department/Hematologic Diseases Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, AL, China
⁴The Second Affiliated Hospital of Anhui Medical University, Hefei, China

Hind Rafei, MD¹, Rafet Basar, MD^1*, Sunil Acharya, PhD^1*, Patrick Zhang, PhD^1*, Pinghua Liu, PhD^1*, Sadie Mae Moseley^1*, Ping Li^1*, May Daher, MD¹, Nitin Agarwal, MS, PhD^2*, Mario L. Marques-Piubelli, MD³, Nadima Uprety^1*, Luciana Melo Garcia, MD, MSc⁴, Mayra Shanley, PhD^1*, Pinaki Banerjee, PhD^1*, Ye Li, MD, PhD¹, Samuel Levi Rosemore^1,5*, Bijender Kumar, PhD^1*, Ana K. Nunez Cortes, MD^1*, Alexander Biederstädt, MD^1*, Sanjida Islam^1*, Mecit Kaplan¹, Bingqian Hu^1*, Gohar Manzar, MD PhD^6*, Paul Lin, MD, PhD¹, David Marin, MD¹, Richard E. Champlin, MD¹, Francisco Vega, MD, PhD⁷, Elizabeth J. Shpall, MD¹ and Katy Rezvani, MD⁸

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴CHU de Québec - Université Laval, Quebec, QC, Canada
⁵Department of Biology, University of Maryland, Baltimore, MD
⁶Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

Danny Luan, MD, MPH¹, Roni Shouval, MD, PhD², Teng Fei, PhD^3*, Efrat Luttwak, MD⁴, Alejandro Luna, MD, PhD^5,6*, Magdalena Corona, MD^2*, Maria Lia Palomba, MD⁷, Allison Parascondola, MPH^8*, Michael Scordo⁹, Gunjan L. Shah⁶, Susan DeWolf, MD¹⁰ and Miguel-Angel Perales, MD⁹

¹Newyork-Presbyterian Hospital/Weill Cornell Medical College, Astoria, NY
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Hospital Universitario Ramon y Cajal, Department of Adult Bone Marrow Transplantation, Madrid, Spain
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁸Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sergio Rutella, MD, PhD, FRCPath¹, Jayakumar Vadakekolathu, PhD^1*, Amanda F Cashen², Nitin Mahajan, PhD, MSc, MS^3*, Yanira Ruiz-Heredia, PhD^4*, Alejandro Martín-Muñoz^4*, Santiago Barrio^4*, Melissa M Berrien-Elliott, PhD^2*, Jan Davidson-Moncada, MD, PhD, MSc⁵ and Todd A Fehniger, MD, PhD⁶

¹John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
²Washington University School of Medicine in St. Louis, St Louis, MO
³Wugen, St Louis, MO
⁴Altum Sequencing Co., Madrid, Spain
⁵Wugen, Washington, DC
⁶Washington University School of Medicine in St. Louis, Saint Louis, MO

Scott R. Goldsmith¹, Geoffrey P. Shouse, PhD, DO², F. Lennie Wong, PhD³, Alysia Bosworth^4*, Aleksi Iujuridze^4*, Sitong Chen, MPH^4*, June-Wha Rhee^4*, Matthew G. Mei, MD⁴, Murali Janakiram, MD, MS⁵, Myo Htut, MD⁶, Stephen J. Forman, MD, FACP⁷, Raju Pillai, MD^8*, Elizabeth Lihua Elizabeth Budde, MD, PhD⁹ and Saro Armenian, DO, MPH⁴

¹Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³City of Hope, Duarte, CA
⁴City of Hope National Medical Center, Duarte, CA
⁵Division of Myeloma, Department of Hematology, City of Hope National Medical Center, Duarte, CA
⁶City of Hope Comprehensive Cancer Center, Duarte, CA
⁷Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
⁸Department of Pathology, City of Hope National Comprehensive Cancer Center, Duarte, CA
⁹Department of Hematology and HCT, City of Hope, Duarte, CA

Kunho Chung, PhD¹, Wooram Jung, PhD^2*, Jae U Jung, PhD^2* and J. Joseph Melenhorst, PhD¹

¹Cell Therapy and Immuno-Engineering Program, Center for ImmunoTherapy & Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
²Department of Cancer Biology, Infection Biology Program, and Global Center for Pathogen Research and Human Health, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

Jennifer Cimons, BSc^1,2*, Kole R. Degolier^1,2*, Michael Yarnell, BSc^3*, M. Eric Kohler, MD, PhD³ and Terry J. Fry, MD^3,4

¹Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Denver, CO
²Immunology Graduate Program, University of Colorado School of Medicine, Aurora, CO
³Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Aurora, CO
⁴Sana Biotechnology, Seattle, WA

Amanda Eckstrom, B.S.^1*, Anudishi Tyagi, PhD^1*, Maryam Siddiqui, B.S.A.^1*, Sajid Mahmood, Ph.D., M.S., DVM^2*, Lilly Wong, Ph.D.^2*, Bahram Bob Valamehr, Ph.D.², Naval Daver, MD¹ and Venkata Lokesh Battula, PhD³

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Fate Therapeutics, San Diego, CA
³Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX

Michael T. Monte^1*, Han Gu^1*, Laura Saunders^1*, Mohit Gupta^1*, Lei Liu^1*, Apiwat Wangweerawong^1*, Thomas V. Colace^1*, Aaron Zannini^1*, Lorenzo Tozzi^1*, Yu Cao^1*, Giulia Schiroli^1*, William E. Salomon^1*, James B. Rottman^1*, Rahul Palchaudhuri^1*, Ulrike Gerdemann^2,3,4, Lev Gorfinkel^2,3,4, Francesca Alvarez Calderon^2,3,4, Leslie Kean^2,3,4, Hari Pujar^1* and Z. Jane Wang^1*

¹Tessera Therapeutics, Somerville, MA
²Dana-Farber Cancer Institute, Boston, MA
³Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA
⁴Harvard Medical School, Boston, MA

Cameron McDonald-Hyman, MD, PhD¹, Ethan G Aguilar, PhD^2*, Stephanie Y Rhee, PhD^2*, Fathima A Mohamed, BA, BS², Ewaldus Compeer, PhD^3*, Timothy Sparwassar, MD^4*, Michael Dustin, PhD^3* and Bruce R Blazar, MD²

¹Department of Medicine, Division of Hematology/Oncology/Transplantation, University of Minnesota, Minneapolis, MN
²Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
³The Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
⁴Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

Wenjun Zhu, MD, PhD^1*, Conor Kelly, MSc^2*, Pradeep Dagur, PhD^3*, Cynthia E. Dunbar, MD⁴ and Stefan Cordes, MD, PhD⁵

¹Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD
²Georgetown University School of Medicine, Washington, DC
³NHLBI, Bethesda, MD
⁴Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
⁵Translational Stem Cell Biology Branch, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Danielle C Kirkey, MD^1,2, Leila Robinson^1*, Tiffany Hylkema, BS^3*, Anisha Loeb, BA^1*, Rhonda E Ries, MA^3*, Cyd McKay^1*, Christina Root^1*, Laura Pardo, MS^1,4*, Keith R. Loeb, MD, PhD⁵, Quy Le, PhD^5*, David A. Scheinberg, MD, PhD⁶ and Soheil Meshinchi, MD, PhD⁷

¹Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
²Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
³Translational Sciences and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
⁴Hematologics, Inc., Seattle, WA
⁵Fred Hutchinson Cancer Center, Seattle, WA
⁶Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA

Sylvain Simon, PhD^1*, Grace Bugos^2,3*, Rachel Prins^1*, Anusha Rajan^1*, Arulmozhi Palani^4*, Kersten Heyer^1* and Stanley R. Riddell, MD^1,5

¹Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
²Translational Science and Therapeutics Division, Fred Hutchinson cancer center, Seattle, WA
³Department of Immunology, University of Washington, Seattle, WA
⁴Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, France
⁵University of Washington, Seattle, WA

Xinyi Teng^1*, Mi Shao^1*, Xin Guo^2*, Tao Cheng^3,4, Pengxu Qian, PhD^5,6,7* and He Huang^8,9,10*

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Med, Hangzhou, CHN
²Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
³Tianjin Institutes of Health Science, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁵Institute of Hematology, Zhejiang University, Hangzhou, China
⁶Liangzhu Laboratory, Zhejiang University, Hangzhou, China
⁷Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Zhejiang University, Hangzhou, China
⁸Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁹Liangzhu Laboratory, Zhejiang University Medical Center, HangZhou, China
¹⁰Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Sunil Acharya, PhD^1*, Rafet Basar, MD^1*, May Daher, MD¹, Ping Li^1*, Hind Rafei, MD², Nadima Uprety^1*, Emily Ensley^1*, Mayra Shanley, PhD^1*, Bijender Kumar, PhD^1*, Pinaki Banerjee, PhD^1*, Luciana Melo Garcia, MD, MSc^1,3, Paul Lin, MD, PhD¹, Vakul Mohanty, PhD^4*, Yuchen Pan^4*, Qi Miao^4*, Kun Hee Kim^4*, Xianli Jiang, PhD^4*, Ye Li, MD, PhD¹, Bin Liu, PhD^1*, Ana K. Nunez Cortes, MD^1*, Patrick Zhang, PhD^1*, Mohsen Fathi, PhD^5,6*, Ali Rezvan, PhD^6*, Melisa J Montalvo^6*, Enli Liu, MD^1*, Navin Varadarajan, PhD^6*, Ken Chen, PhD^4*, David Marin, MD¹, Richard E. Champlin, MD¹, Elizabeth J. Shpall, MD¹ and Katy Rezvani, MD⁷

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Missouri City, TX
³CHU de Québec - Université Laval, Quebec, QC, Canada
⁴Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵CellChorus, Inc., Houston, TX
⁶Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

William Lin^1,2,3*, Ditsa Sarkar, PhD, MSc^2,3,4, Joanna Y Kim^2,3,4*, Nelson H Knudsen, PhD^4,5,6*, Isabel C Lane^2,3,4*, Andi Cheng^4,5,6*, Gabriele Kembaun^2,3,4*, Tamina Kienka^3,4*, Jeannie Carreiro^5,7*, Amanda A Bouffard^3,4*, Marcela V Maus, MD, PhD^3,8,9, Robert T Manguso, PhD^4,5,6* and Max Jan, MD, PhD^2,3,4,5

¹Cancer Center, Massachusetts General Hospital, Charlestown, MA
²Department of Pathology, Massachusetts General Hospital, Boston, MA
³Harvard Medical School, Boston, MA
⁴Cancer Center, Massachusetts General Hospital, Boston, MA
⁵Broad Institute of MIT and Harvard, Boston, MA
⁶Department of Medicine, Massachusetts General Hospital, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA
⁹Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA

Aluya Richard Oseghale, PhD^1*, Alice Bertaina, MD, PhD² and Matthew Porteus, MD, PhD³

¹Pediatrics, Stanford University, Stanford, CA
²Stanford University, Palo Alto, CA
³Department of Pediatrics, Stanford University, Stanford, CA

Alka Dwivedi, PhD¹, Lynn Fu^2*, Chris Daniel Chien, Ph.D.², Marie Pouzolles, Ph.D.², Nirali N. Shah, M.D.² and Naomi Taylor, M.D., Ph.D.²

¹Pediatric Oncology Branch, National Institute of Health, Bethesda, MD
²Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD

Klesti Karaxhuku, MSc, BSc^1*, Kanagaraju Ponnusamy, PhD, MSc, BSc^1*, Hongwei Ren, MD, PhD^2*, Bryan Lye, M. Phil^2*, Ilia Leontari^1*, Mehmood Zaidi^2*, Farah Sabrin^2*, Marco Bua^3*, Maria Atta^1*, Alexia Katsarou^4*, Irene Roberts, MD^5,6, Aristeidis Chaidos, MD, PhD^1,3* and Anastasios Karadimitris, MD, PhD^1,3*

¹Hugh & Josseline Langmuir Centre for Myeloma Research Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
²Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
³Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴Imperial College London, London, GBR
⁵Department of Paediatrics, University of Oxford, Oxford, United Kingdom
⁶Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

Ron Ram, MD¹, Yonatan Katzenelenbogen, PhD^2*, Anna Gurevich Shapiro, MD, MPhil^3*, Eitan Winter, MSc^2*, Oren Barboy, MSc^2*, Mor Zada, MSc^2*, Shahar Halevi^2*, Eyal David^2*, Irit Avivi Mazza, MD^1* and Ido Amit, PhD^2*

¹BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel
³Department of Systems Immunology, Weizmann Institute of Science, Tel Aviv, AL, Israel

Mirco Julian Friedrich, MD, PhD^1,2*, Michael Kilian, PhD^2*, Kevin Hai-Ning Lu^2*, Selina Jansky^2*, Julius Michel^2*, Anna Keib^3*, David Vonhören^2*, Nicolaj Hackert^3*, Markus Hahn^2*, Adelheid Cerwenka^4*, Felix Sahm^5*, Frank Westermann^2*, Peter Dreger, MD³, Marc S. Raab^3*, Nadja M. Meindl-Beinker^6*, Matthias Ebert^6*, Lukas Bunse, MD^2*, Carsten Müller-Tidow, MD^3*, Michael Schmitt^3* and Michael Platten, MD^2,7*

¹Broad Institute of MIT and Harvard, Cambridge, MA
²German Cancer Research Center (DKFZ), Heidelberg, Germany
³Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
⁴Mannheim Institute of Innate Immunoscience (MI3), Medizinische FakultäT M, Mannheim, Germany
⁵Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany
⁶Department of Medicine II, Medical Faculty Mannheim, Mannheim, Germany
⁷Department of Neurology, Medical Faculty Mannheim, Mannheim, Germany

Muharrem Muftuoglu, MD¹, Mahesh Basyal, BSc^2*, Li Li, MD^1*, Jiangxing Lv^1*, Lauren B. Ostermann, BSc^1*, Ran Zhao, MS^1*, Baozhen Ke, BS^1*, Hiroki Akiyama, MD, PhD¹, Po Yee Mak^1*, Bing Z. Carter, PhD¹, Han Deng, PhD^3*, Yongshuai Li^4*, Brian S. Garrison, PhD^3*, Kanya L. Rajangam, MD, PhD^3* and Michael Andreeff, MD PhD⁵

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Senti Biosciences, South San Francisco, CA
⁴Senti Biosciences, South San Francisco
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Andrew P Jallouk, MD, PhD^1,2, Zhongqi Ge, PhD^1*, Vivek Kaimal, PhD^3*, Tom Furmanak, M.S.^3*, Cesar Sommer, PhD³, Elvin J Lauron, PhD^3*, Barbra J. Sasu, PhD^3*, Sattva S. Neelapu, MD⁴ and Pavan Bachireddy, MD¹

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
³Allogene Therapeutics, South San Francisco, CA
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Wei-Hsin Liu, MD¥^1*, Anat Globerson Levin, Ph.D¥^2*, Assaf Lask, Ph.D¥^3*, Galit Horn, Ph.D^2*, Tova Waks, M.Sc.^2,3*, Bar Nathansohn Levy, Ph.D^3*, Maksim Mamonkin, Ph.D⁴, Zelig Eshhar, Ph.D^3*, Richard E. Champlin, MD¹, Yair Reisner, PhD¹ and Esther Bachar Lustig, Ph.D^1*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Dotan Center for Advanced Therapies, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel
³Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
⁴Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX

Nupur Bhatnagar^1*, Vincent Petit^2*, Jayakumar Vadakekolathu, PhD^3*, Christian Pinset^1*, Nitin Mahajan, PhD, MSc, MS^4*, John Dean^4*, Christine Spingola^5*, Laura Arthur, PhD^6*, David Boocock, PhD^7*, Clare Coveney, PhD^7*, John Muth, MSc^8*, Jan Baughman, MPH^9*, Melissa M Berrien-Elliott, PhD^10*, Marc Sitbon^11*, Matthew L. Cooper, PhD¹², Jan Davidson-Moncada, MD, PhD, MSc¹³, Todd A Fehniger, MD, PhD¹⁴ and Sergio Rutella, MD, PhD, FRCPath³

¹Metafora Biosystems, Paris, France
²Metafora Biosystems, Paris, FRA
³John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
⁴Wugen, St. Louis
⁵Wugen, St Louis
⁶Wugen, Saint Louis, MO
⁷Nottingham Trent University, Nottingham, United Kingdom
⁸Wugen, St. Louis, MO
⁹Alviso Clinical Research, San Francisco
¹⁰Washington University at St. Louis, Saint Louis, MO
¹¹National Institutes of Health, Bethesda
¹²Wugen Inc., Saint Louis, MO
¹³Wugen, Washington, DC
¹⁴Washington University School of Medicine in St. Louis, Saint Louis, MO